Patients w/ Down's syndrome, hepatic or renal disease & hyperthyroidism, conditions characterized by tachycardia, gastric ulcer, GERD, hiatal hernia reflux esophagitis, autonomic neuropathy, partial obstructive uropathy & diarrhea, those w/ known or suspected GI infections eg,
C. difficile-associated diarrhea & colitis, shigellosis & dysentery, mild to moderate ulcerative colitis, pyrexia. Increased IOP. Anaphylaxis has been reported after parenteral administration.